Does Beam Therapeutics Inc (NASDAQ: BEAM) Still Look Attractive After A 7.21% Selloff Last Week?
During the last session, Beam Therapeutics Inc (NASDAQ:BEAM)’s traded shares were 1.4 million, with the beta value of the company hitting 1.87. At the end